Join the community - networking, discussion and more. Open to all.
More informationCould you write an interesting article for the RQA community?
More informationTargeted stakeholder consultation on the amendments to Commission Implementing Regulation (EU) 520/2012 on pharmacovigilance activities
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 30 August – 2 September 2021
Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 7-9 September 2021
The Medicines and Healthcare products Regulatory Agency (MHRA) is inviting members of the public to provide their views on possible changes to the regulatory framework for medical devices in the United Kingdom (UK).
Major milestone reached in the combined review journey
Software and AI as a Medical Device Change Programme
MHRA launches public consultation on future of medical device regulation
The second Medicines and Healthcare products Regulatory Agency (MHRA) and US Food and Drug Administration (FDA) joint Good Clinical Practice (GCP) symposium was held in London in February 2020.
The joint HMA/EMA Big Data Steering Group workplan aims to increase the utility of big data in medicine regulation. A new workplan, extended to March 2023, is now available.
Help shape the event.